Related Experiment Video
Updated: Aug 19, 2026

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
Published on: October 13, 2018
Liposome-bilirubin interaction: a novel strategy to eliminate bilirubin from systemic circulation
Alam Khan Masood1, Shagufta Moin, Saad Tayyab
1Inter-disciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh 202002, India.
Abstract:
In the present study, we established the role of liposomes in removal of bilirubin from systemic circulation of the hyperbilirubinemic rats. Bilirubin has been demonstrated to possess inherent tendency to interact with liposomes through ionic as well as hydrophobic interactions. The size as well as lamellarity of the liposomes does not seem to affect their binding with bilirubin. However, the charge on the surface of liposomes plays an important role in bilirubin-liposome interaction, e.g., bilirubin binds more extensively with positively charged liposomes as compared to the neutral or negatively charged liposomes. The present study further demonstrates that liposomes were effective in reducing the increased plasma bilirubin level in hyperbilirubinemic model animals as well. The results of the study suggest that positively charged liposome-mediated selective homing of excess plasma bilirubin to the hepatocytes seems to offer an important strategy in management of hyperbilirubinemic conditions.
Related Concept Videos
Jaundice
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Drug Biotransformation: Overview
Drug Elimination: Non-Renal Routes
Bioavailability Enhancement: Drug Permeability Enhancement
Hepatic Drug Excretion: Influencing Factors
